Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Journal of Critical Care|December 8, 2020
Short-and long-term outcomes of sustained low efficiency dialysis vs continuous renal replacement therapy in critically ill patients with acute kidney injuryAndrea K Harvey, Karen E A Burns, Eric McArthur, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
The epigenomic landscape of single vascular cells reflects developmental origin and identifies disease risk lociChad S Weldy, Soumya Kundu, João Monteiro, et al.
Molecular Systems Biology|September 10, 2025
Epigenomic landscape of single vascular cells reflects developmental origin and disease risk lociChad S Weldy, Soumya Kundu, João Monteiro, et al.
Annals of Neurology|May 11, 2019
Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapyJuliane Gust, Olivia C Finney, Daniel Li, et al.
Redox Biology|June 9, 2026
Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killingTaufeeque Ali, Thilini Nimasha Fernando Ponnamperumage, Cody Joshua Miller, et al.
JMIR Research Protocols|October 27, 2020
Repetitive Transcranial Magnetic Stimulation With and Without Internet-Delivered Cognitive-Behavioral Therapy for the Treatment of Resistant Depression: Protocol for Patient-Centered Randomized Controlled Pilot TrialRabab M Abou El-Magd, Gloria Obuobi-Donkor, Medard K Adu, et al.
Cancer Discovery|October 14, 2017
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T CellsJuliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, et al.
The American Journal of Tropical Medicine and Hygiene|December 21, 2016
Evaluation of the GeneXpert for Human Monkeypox DiagnosisDaniel Li, Kimberly Wilkins, Andrea M McCollum, et al.
Cancer Discovery|June 9, 2018
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic LeukemiaBianca D Santomasso, Jae H Park, Darin Salloum, et al.
Lancet (London, England)|September 5, 2020
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design studyJeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
Pageof 19